Intrinsic value of Barinthus Biotherapeutics plc (BRNS)
Live fair value data for Barinthus Biotherapeutics plc (BRNS) is currently unavailable. Please check again shortly.
Current Price: $49.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Barinthus Biotherapeutics plc (BRNS) undervalued or overvalued?
Based on the current model output, Barinthus Biotherapeutics plc appears to be undervalued with a upside of 47.00%.
Fair value vs market price — Barinthus Biotherapeutics plc (BRNS)
Unlock premium access to view the live fair value comparison against current market price for BRNS.
Frequently Asked Questions - BRNS
How is BRNS intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for BRNS.
Is BRNS undervalued or overvalued right now?
BRNS is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for BRNS: open their intrinsic value pages.